Physician Wealth Advisors’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.3K Buy
319
+43
+16% +$2.36K ﹤0.01% 719
2026
Q2
$10.7K Buy
276
+179
+185% +$9.43K ﹤0.01% 858
2026
Q1
$5.95K Sell
97
-245
-72% -$17.5K ﹤0.01% 950
2025
Q4
$28.4K Buy
342
+213
+165% +$15.9K ﹤0.01% 501
2025
Q3
$8.65K Buy
129
+108
+514% +$7.81K ﹤0.01% 783
2025
Q2
$1.64K Buy
+21
New +$1.61K ﹤0.01% 1130

Other funds holding CTSH

Physician Wealth Advisors's CTSH Position: Q3 2026 in Review

Physician Wealth Advisors increased its Cognizant (CTSH) stake by 16% in Q3 2026, buying an estimated $2.36K and bringing the position to 319 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

Physician Wealth Advisors first reported a position in CTSH in Q2 2025 and has held it in 6 quarters since. The position peaked at $28.4K in Q4 2025. 816 funds tracked by Wall St. Rank hold CTSH as of Q3 2026.

  • Physician Wealth Advisors held 319 shares of Cognizant worth $18.3K as of Q3 2026.
  • Physician Wealth Advisors bought 43 Cognizant shares in Q3 2026, an estimated $2.36K.
  • Cognizant made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #719 holding.
  • Physician Wealth Advisors first reported a position in Cognizant in Q2 2025 and has held it in 6 quarters since.
  • Physician Wealth Advisors's Cognizant position peaked at $28.4K in Q4 2025.
  • 816 funds tracked by Wall St. Rank held Cognizant as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.